Home › Sclerosing Cholangitis › Texas
Sclerosing Cholangitis clinical trials in Texas
3 studies for Sclerosing Cholangitis are looking for participants at sites in Texas.
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Methodist Health Systems Clinical Research Institute, Dallas
- University of Texas Southwestern Medical Center, Dallas
- Baylor College of Medicine - Advanced Liver Therapies, Houston
- and 4 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- UT Southwestern Medical Center, Dallas
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT05750498Primary Sclerosing Cholangitis in Children
- Texas Children's Hospital (Baylor College of Medicine), Houston
RecruitingObservational study
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.